Transdel Pharmaceuticals Will Host Shareholder Update Call on Thursday, February 7, 2008 at 4:15 p.m. Eastern Time
           

LA JOLLA, CA--(Marketwire - February 5, 2008) -  Transdel Pharmaceuticals, Inc. (OTCBB: TDLP),
a specialty pharmaceutical company focused on the development and
commercialization of non-invasive topically delivered medications, today
announced that Dr. Juliet Singh, President and CEO, and John Lomoro, CFO,
will host a conference call to update shareholders on the business
developments that have taken place, which will be followed by a question
and answer period.

           

http://www.marketwire.com/mw/release.do?id=817633&sourceType=3